[1] |
DE ZUBIRIA SALGADO A,HERRERA-DIAZ C. Lupus nephritis:an overview of recent findings[J]. Autoimmune Dis,2012,2012:849684.
|
[2] |
REKVIG O P,VAN DER VLAG J. The pathogenesis and diagnosis of systemic lupus erythematosus:still not resolved[J]. Semin Immunopathol,2014,36(3):301-311.
|
[3] |
FAGGIONI R,FEINGOLD K R,GRUNFELD C.Leptin regulation of the immune response and the immunodeficiency of malnutrition[J]. FASEB J,2001,15(14):2565-2571.
|
[4] |
FANTUZZI G.Adiponectin in inflammatory and immune-mediated diseases[J]. Cytokine,2013,64(1):1-10.
|
[5] |
彭英兰,高锦团. 血清脂联素与尿蛋白在SLE患者体内的表达及意义[J]. 内蒙古医学杂志,2015,47(8):944-946.
|
[6] |
王晓华,何杏容. 女性狼疮性肾炎患者血清IL-6及瘦素检测的意义[J]. 中国临床研究,2015,28(6):747-749.
|
[7] |
张力奋,夏成云,权志慧,等. 血清瘦素和白细胞介素-6及肿瘤坏死因子-α水平与狼疮性肾炎的相关性研究[J]. 国际泌尿系统杂志,2015,35(6):915-919.
|
[8] |
麻贞贞,孙红胜,杨清锐. 脂联素、内脂素、抵抗素在系统性红斑狼疮患者血清中的变化及临床意义[J]. 山东大学学报(医学版),2017,55(4):86-90.
|
[9] |
石连杰,李春,朱佳鑫,等. 系统性红斑狼疮最新分类标准诞生[J]. 中华风湿病学杂志, 2012,16(10):713-714.
|
[10] |
SCHWARTZ N,GOILAV B,PUTTERMAN C.The pathogenesis,diagnosis and treatment of lupus nephritis[J]. Curr Opin Rheumatol,2014,26(5):502-509.
|
[11] |
MAROZ N,SEGAL M S.Lupus nephritis and end-stage kidney disease[J]. Am J Med Sci,2013,346(4):319-323.
|
[12] |
MISRA R,GUPTA R.Biomarkers in lupus nephritis[J]. Int J Rheum Dis,2015,18(2):219-232.
|
[13] |
TOUSSIROT E,STREIT G,WENDLING D.The contribution of adipose tissue and adipokines to inflammation in joint diseases[J]. Curr Med Chem,2007,14(10):1095-1100.
|
[14] |
KRYSIAK R,HANDZLIK-ORLIK G,OKOPIEN B.The role of adipokines in connective tissue diseases[J]. Eur J Nutr,2012,51(5):513-528.
|
[15] |
DIAZ-RIZO V,BONILLA-LARA D,GONZALEZ-LOPEZ L,et al.Serum levels of adiponectin and leptin as biomarkers of proteinuria in lupus nephritis[J]. PLoS One,2017,12(9):e0184056.
|
[16] |
MAHIEU M A,AHN G E,CHMIEL J S,et al.Serum adipokine levels and associations with patient-reported fatigue in systemic lupus erythematosus[J]. Rheumatol Int,2018,38(6):1053-1061.
|